Published in Medical Verdicts and Law Weekly, March 9th, 2006
AspenBio has also recently filed a further separate patent application seeking to expand its worldwide position of intellectual property protection associated with this technology. In connection with the advancement of the test, the company has also signed a licensing agreement, securing access to a critical technology element which ensures a continuing supply of an important test...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Verdicts and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.